Sponsor:
TScan Therapeutics, Inc.
Code:
NCT05473910
Conditions
AML
Myelodysplastic Syndromes
ALL, Adult
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
SOC + TSC-100
SOC + TSC-101
Control
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-31. This information was provided to ClinicalTrials.gov by TScan Therapeutics, Inc. on 2025-05-18.